The Rise of Altcoins Won't Eclipse Bitcoin Just Yet
Sure different forms of cryptocurrencies may be surging, but you might not want to write-off Bitcoin...at least not yet!
Jake Yocom-Piatt, the project lead at fellow cryptocurrency Decred, told Cheddar that the newly-discovered coins might not be eclipsing Bitcoin anytime soon.
“For all we know Bitcoin may fall, but right now it’s the dominant cryptocurrency and it looks like it’s going to stay that way, at least for the short-term,” he said. “Whether that’s going to remain the case in the longer term it’s hard to say.”
But investors are exploring other options. Tron, which launched last September, has leapt into the top 10 in terms of market cap in just four months. Its most recent surge was helped by founder Justin Sun’s announcement this week that Tron will announce a partnership with a “prestigious public” company next week.
For full interview [click here](https://cheddar.com/videos/will-altcoins-eclipse-bitcoin).
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
